Debt-funded M&A increased total debt to $26.6B and D/E to 0.50, while goodwill rose to $47.4B, representing 51% of total assets, signaling elevated leverage and impairment risk.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 13.38B | 12.76B | 9.5B | 13.94B | 15.88B | 11.65B | 13.8B | 25.6B | 7.09B | 6.85B | 6.67B | 7.84B | 9.43B | 9.11B | 7.59B | 6.27B | 5.73B | 5.22B | 4.19B | 4.05B | 3.39B | 2.95B | 2.92B | 2.94B | 2.39B | 1.87B | 1.47B | 1.2B | 886.9M | 618.3M | 546.7M |
| Cash & Short-Term Investments | 4.35B | 4.62B | 2.08B | 5.86B | 6B | 2.59B | 6.04B | 19.91B | 787.8M | 630.3M | 963.7M | 790.8M | 3.01B | 3.12B | 1.68B | 537M | 1.63B | 1.72B | 392.85M | 239.11M | 317.81M | 315.55M | 609.12M | 1.23B | 810.46M | 706.56M | 176.92M | 260.3M | 41.9M | 33.3M | 26.4M |
| Cash Only | 4.35B | 4.62B | 2.08B | 5.86B | 6B | 2.59B | 6.04B | 19.91B | 787.8M | 630.3M | 963.7M | 790.8M | 3.01B | 3.12B | 1.68B | 537M | 1.63B | 1.72B | 392.85M | 239.11M | 317.81M | 315.55M | 609.12M | 1.23B | 810.46M | 706.56M | 176.92M | 260.3M | 41.9M | 33.3M | 26.4M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.96B | 3.91B | 4.39B | 4.64B | 5.06B | 5.44B | 4.81B | 3.27B | 3.11B | 3.52B | 3.19B | 2.99B | 3.63B | 3.45B | 3.27B | 3.05B | 2.22B | 1.92B | 1.89B | 1.98B | 1.67B | 1.41B | 1.23B | 868.1M | 759.03M | 585.32M | 704.21M | 544.7M | 467.1M | 322.6M | 266.7M |
| Days Sales Outstanding | 56.16 | 58.13 | 67.11 | 70.85 | 69.38 | 67.45 | 78.79 | 66.6 | 66.62 | 70.13 | 68.88 | 75.49 | 66.6 | 65.9 | 65.31 | 69.18 | 61.35 | 62.55 | 54.46 | 65.69 | 63.71 | 64.36 | 65.22 | 59.85 | 60.53 | 56.48 | 68.04 | 62.18 | 58.59 | 57.41 | 53.73 |
| Inventory | 3.26B | 2.49B | 2.33B | 2.59B | 2.77B | 2.77B | 2.29B | 1.63B | 1.63B | 1.84B | 1.71B | 1.57B | 1.83B | 1.78B | 1.81B | 1.78B | 1.23B | 993.02M | 1.14B | 1.19B | 1.01B | 825.26M | 704M | 536.23M | 485.59M | 408.24M | 460.61M | 324.7M | 323.5M | 209.4M | 204.2M |
| Days Inventory Outstanding | 96.64 | 94.65 | 87.96 | 96.06 | 96.53 | 87.81 | 85.29 | 74.97 | 78.94 | 82.96 | 83.2 | 88.07 | 70.93 | 71.27 | 75.11 | 82.87 | 68 | 62.68 | 62.01 | 72.79 | 68.55 | 66.35 | 64.29 | 62.04 | 63.5 | 63.73 | 77.62 | 64.61 | 68.95 | 58.51 | 63.64 |
| Other Current Assets | 1.81B | 1.74B | 79M | 71M | 1.36B | 82M | 665M | 787.6M | 1.56B | 857.1M | 805.9M | 2.49B | 960.4M | 763.4M | 828.4M | 904.11M | 652.41M | 588.86M | 0 | 632.66M | 396.76M | 396.35M | 374.51M | 0 | 0 | 0 | 132.56M | 72.4M | 54.4M | 53M | 49.4M |
| Total Non-Current Assets | 78.99B | 70.71B | 68.05B | 70.55B | 68.47B | 71.54B | 62.36B | 36.48B | 40.74B | 39.8B | 38.63B | 40.39B | 27.56B | 25.56B | 25.35B | 23.68B | 16.49B | 14.37B | 13.3B | 13.42B | 9.47B | 6.22B | 5.58B | 3.95B | 3.64B | 2.95B | 2.56B | 1.84B | 1.85B | 1.26B | 1.22B |
| Property, Plant & Equipment | 5.83B | 6.75B | 6.07B | 5.61B | 4.59B | 4.83B | 4.2B | 3.07B | 2.25B | 2.45B | 2.35B | 2.3B | 2.2B | 2.21B | 2.14B | 2.1B | 1.19B | 1.14B | 1.11B | 1.11B | 874.37M | 748.17M | 752.97M | 573.37M | 597.38M | 533.57M | 575.53M | 500.2M | 471M | 335.2M | 319.6M |
| Fixed Asset Turnover | 4.08x | 3.64x | 3.93x | 4.26x | 5.80x | 6.10x | 5.30x | 5.84x | 7.58x | 7.47x | 7.17x | 6.27x | 9.04x | 8.65x | 8.53x | 7.66x | 11.07x | 9.78x | 11.45x | 9.95x | 10.98x | 10.67x | 9.15x | 9.23x | 7.66x | 7.09x | 6.56x | 6.39x | 6.18x | 6.12x | 5.67x |
| Goodwill | 47.41B | 43.15B | 40.5B | 41.61B | 37.28B | 41.18B | 35.42B | 22.71B | 22.58B | 25.14B | 23.83B | 21.01B | 16.96B | 16.04B | 15.46B | 14.47B | 10.76B | 9.82B | 9.21B | 9.24B | 6.6B | 4.47B | 3.97B | 0 | 0 | 2.29B | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 21.36B | 17.82B | 18.57B | 20.75B | 19.82B | 22.84B | 21.28B | 9.75B | 10.28B | 11.67B | 11.82B | 10.55B | 7.37B | 6.25B | 6.34B | 5.84B | 3.32B | 2.66B | 2.52B | 2.56B | 1.7B | 834.15M | 760.26M | 3.34B | 3.01B | 0 | 1.86B | 1.29B | 1.28B | 853.4M | 792.8M |
| Long-Term Investments | 4.7B | 1.55B | 1.81B | 1.7B | 2.16B | 1.32B | 27M | 33.7M | 38.3M | 45.4M | 170.1M | 401.4M | 257.5M | 385.2M | 877.8M | 808.88M | 768.28M | 219.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.39B | 1.45B | 1.09B | 896M | 4.61B | 1.36B | 1.43B | 923.4M | 5.59B | 492.9M | 461.2M | 6.12B | 766.5M | 676.1M | 528.5M | 452.69M | 444.13M | 538.91M | 464.35M | 507.55M | 300.43M | 160.78M | 91.7M | 32.56M | 36.8M | 119.64M | 117.94M | 52.5M | 96.2M | 72.8M | 106M |
| Total Assets | 92.37B | 83.46B | 77.54B | 84.49B | 84.35B | 83.18B | 76.16B | 62.08B | 47.83B | 46.65B | 45.3B | 48.22B | 36.99B | 34.67B | 32.94B | 29.95B | 22.22B | 19.6B | 17.49B | 17.47B | 12.86B | 9.16B | 8.49B | 6.89B | 6.03B | 4.82B | 4.03B | 3.05B | 2.74B | 1.88B | 1.77B |
| Asset Turnover | 0.30x | 0.29x | 0.31x | 0.28x | 0.32x | 0.35x | 0.29x | 0.29x | 0.36x | 0.39x | 0.37x | 0.30x | 0.54x | 0.55x | 0.55x | 0.54x | 0.59x | 0.57x | 0.73x | 0.63x | 0.75x | 0.87x | 0.81x | 0.77x | 0.76x | 0.78x | 0.94x | 1.05x | 1.06x | 1.09x | 1.03x |
| Asset Growth % | 25.51% | 7.64% | -8.22% | 0.16% | 1.4% | 9.22% | 22.68% | 29.79% | 2.54% | 2.99% | -6.07% | 30.36% | 6.69% | 5.26% | 9.99% | 34.8% | 13.38% | 12.04% | 0.1% | 35.82% | 40.39% | 7.88% | 23.28% | 14.28% | 25.07% | 19.57% | 32.31% | 11.26% | 45.7% | 6.49% | 18.78% |
| Total Current Liabilities | 8.11B | 6.81B | 6.8B | 8.27B | 8.39B | 8.14B | 7.4B | 4.93B | 4.84B | 4.79B | 6.87B | 6.17B | 5.4B | 4.56B | 4.21B | 4.17B | 3.3B | 2.76B | 2.75B | 2.9B | 2.46B | 2.27B | 2.2B | 1.38B | 1.27B | 1.02B | 1.02B | 708.8M | 688.7M | 524.2M | 474.6M |
| Accounts Payable | 1.82B | 1.84B | 1.75B | 1.77B | 1.86B | 2.57B | 2.05B | 1.51B | 1.5B | 1.51B | 1.49B | 1.39B | 1.88B | 1.78B | 1.55B | 1.42B | 1.22B | 1.05B | 1.11B | 1.13B | 952.34M | 782.85M | 612.07M | 472.99M | 366.59M | 235.5M | 262.1M | 213.21M | 161.8M | 152.1M | 110.2M |
| Days Payables Outstanding | 62.67 | 70.13 | 66.17 | 65.4 | 64.8 | 81.53 | 76.24 | 69.73 | 72.36 | 68.05 | 72.28 | 77.92 | 72.61 | 71.06 | 64.05 | 66.17 | 67.49 | 66.37 | 60.2 | 68.65 | 64.94 | 62.94 | 55.9 | 54.72 | 47.94 | 36.77 | 44.17 | 42.42 | 34.49 | 42.5 | 34.34 |
| Short-Term Debt | 1.41B | 2M | 505M | 1.88B | 758M | 215M | 200M | 370.2M | 51.8M | 194.7M | 2.59B | 845.2M | 71.9M | 62.3M | 55.5M | 98.39M | 40.76M | 44.19M | 66.16M | 330.48M | 10.86M | 183.95M | 424.76M | 14.38M | 112.54M | 72.36M | 81.63M | 33.6M | 59.6M | 35.5M | 16.8M |
| Deferred Revenue (Current) | 0 | 0 | 1.3B | 1.47B | 1.46B | 1.61B | 1.21B | 687.8M | 626.8M | 666M | 539.8M | 457M | 766.5M | 686.5M | 730M | 645M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 4.96B | 1.34B | 1.4B | 2.48B | 1.59B | 1.93B | 921.1M | 1.41B | 978.5M | 954.7M | 2.22B | 1.1B | 883.6M | 843.9M | 926.7M | 1.13B | 944.12M | 0 | 662.27M | 582.75M | 528.02M | 491.23M | 0 | 0 | 0 | 674.81M | 461.99M | 467.3M | 336.6M | 347.6M |
| Current Ratio | 1.65x | 1.87x | 1.40x | 1.68x | 1.89x | 1.43x | 1.86x | 5.19x | 1.47x | 1.43x | 0.97x | 1.27x | 1.75x | 2.00x | 1.80x | 1.50x | 1.73x | 1.89x | 1.53x | 1.40x | 1.38x | 1.30x | 1.33x | 2.13x | 1.89x | 1.84x | 1.45x | 1.70x | 1.29x | 1.18x | 1.15x |
| Quick Ratio | 1.25x | 1.51x | 1.05x | 1.37x | 1.56x | 1.09x | 1.55x | 4.86x | 1.13x | 1.05x | 0.72x | 1.02x | 1.41x | 1.61x | 1.37x | 1.08x | 1.36x | 1.53x | 1.11x | 0.98x | 0.97x | 0.93x | 1.01x | 1.74x | 1.50x | 1.44x | 1.00x | 1.24x | 0.82x | 0.78x | 0.72x |
| Cash Conversion Cycle | 90.12 | 82.66 | 88.9 | 101.51 | 101.11 | 73.74 | 87.83 | 71.85 | 73.2 | 85.04 | 79.81 | 85.63 | 64.92 | 66.11 | 76.37 | 85.88 | 61.86 | 58.86 | 56.27 | 69.84 | 67.32 | 67.77 | 73.62 | 67.17 | 76.09 | 83.45 | 101.49 | 84.37 | 93.05 | 73.42 | 83.02 |
| Total Non-Current Liabilities | 31.68B | 24.12B | 21.19B | 22.72B | 25.87B | 29.87B | 28.98B | 26.87B | 14.76B | 15.49B | 15.34B | 18.29B | 8.15B | 7.66B | 9.65B | 8.81B | 5.14B | 5.2B | 4.94B | 5.49B | 3.76B | 1.81B | 1.67B | 1.86B | 1.75B | 1.57B | 1.07B | 629.5M | 698.2M | 438.6M | 490.2M |
| Long-Term Debt | 25.15B | 18.42B | 15.5B | 16.71B | 19.09B | 22.17B | 21.19B | 21.52B | 9.69B | 10.33B | 9.67B | 12.03B | 3.4B | 3.44B | 5.29B | 5.21B | 2.78B | 2.89B | 2.55B | 3.4B | 2.42B | 857.77M | 925.53M | 1.28B | 1.2B | 1.12B | 713.56M | 341M | 412.9M | 162.7M | 219.6M |
| Capital Lease Obligations | 0 | 0 | 968M | 954M | 772M | 889M | 785M | 652.2M | 0 | 0 | 15.2M | 0 | 28.3M | 55.2M | 40.8M | 40.7M | 23M | 25.9M | 0 | 29.8M | 11.7M | 14.2M | 16.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6.53B | 5.71B | 4.49B | 4.81B | 5.79B | 6.6B | 6.8B | 4.59B | 4.97B | 5.06B | 5.58B | 6.19B | 4.56B | 4.09B | 4.26B | 3.52B | 2.36B | 2.32B | 2.38B | 2.09B | 1.34B | 956.4M | 746.39M | 578.84M | 556.81M | 455.27M | 357.25M | 288.5M | 285.3M | 275.9M | 270.6M |
| Total Liabilities | 39.79B | 30.93B | 27.99B | 31B | 34.26B | 38.01B | 36.38B | 31.8B | 19.61B | 20.28B | 22.22B | 24.46B | 13.54B | 12.22B | 13.86B | 12.98B | 8.44B | 7.97B | 7.68B | 8.39B | 6.22B | 4.08B | 3.87B | 3.24B | 3.02B | 2.59B | 2.09B | 1.34B | 1.39B | 962.8M | 964.8M |
| Total Debt | 26.56B | 18.42B | 17.15B | 19.54B | 20.62B | 23.27B | 22.18B | 22.53B | 9.74B | 10.52B | 12.27B | 12.87B | 3.47B | 3.5B | 5.34B | 5.31B | 2.82B | 2.93B | 2.62B | 3.73B | 2.43B | 1.04B | 1.35B | 1.3B | 1.31B | 1.19B | 795.19M | 374.6M | 472.5M | 198.2M | 236.4M |
| Net Debt | 22.21B | 13.8B | 15.07B | 13.67B | 14.62B | 20.69B | 16.14B | 2.61B | 8.95B | 9.89B | 11.31B | 12.08B | 467.8M | 383.8M | 3.66B | 4.77B | 1.19B | 1.21B | 2.23B | 3.49B | 2.12B | 726.17M | 741.18M | 68.73M | 499.5M | 485.13M | 618.27M | 114.3M | 430.6M | 164.9M | 210M |
| Debt / Equity | 0.50x | 0.35x | 0.35x | 0.37x | 0.41x | 0.52x | 0.56x | 0.74x | 0.35x | 0.40x | 0.53x | 0.54x | 0.15x | 0.16x | 0.28x | 0.31x | 0.21x | 0.25x | 0.27x | 0.41x | 0.37x | 0.21x | 0.29x | 0.36x | 0.44x | 0.53x | 0.41x | 0.22x | 0.35x | 0.22x | 0.30x |
| Debt / EBITDA | 4.05x | 2.43x | 2.28x | 2.62x | 2.13x | 2.28x | 3.64x | 4.95x | 2.29x | 2.40x | 2.98x | 3.90x | 0.76x | 0.82x | 1.32x | 1.57x | 1.07x | 1.41x | 1.14x | 1.87x | 1.41x | 0.72x | 1.08x | 1.33x | 1.58x | 1.75x | 1.13x | 0.64x | 0.99x | 0.58x | 0.80x |
| Net Debt / EBITDA | 3.38x | 1.82x | 2.00x | 1.84x | 1.51x | 2.02x | 2.65x | 0.57x | 2.11x | 2.25x | 2.75x | 3.66x | 0.10x | 0.09x | 0.91x | 1.41x | 0.45x | 0.58x | 0.97x | 1.75x | 1.23x | 0.50x | 0.59x | 0.07x | 0.60x | 0.71x | 0.88x | 0.20x | 0.91x | 0.48x | 0.71x |
| Interest Coverage | 64.05x | 16.97x | 17.71x | 18.45x | 35.52x | 32.53x | 17.47x | 31.44x | 22.64x | 19.06x | 15.16x | 15.59x | 29.38x | 25.44x | 20.12x | 18.28x | 20.40x | 12.62x | 14.44x | 15.92x | 19.12x | 28.47x | 20.24x | - | 15.92x | - | - | - | - | - | - |
| Total Equity | 52.59B | 52.54B | 49.55B | 53.49B | 50.09B | 45.18B | 39.78B | 30.28B | 28.23B | 26.37B | 23.08B | 23.76B | 23.45B | 22.45B | 19.08B | 16.97B | 13.77B | 11.63B | 9.81B | 9.09B | 6.64B | 5.08B | 4.62B | 3.65B | 3.01B | 2.23B | 1.94B | 1.71B | 1.35B | 916.9M | 800.3M |
| Equity Growth % | 10.2% | 6.04% | -7.37% | 6.79% | 10.88% | 13.58% | 31.36% | 7.28% | 7.05% | 14.26% | -2.89% | 1.34% | 4.45% | 17.65% | 12.45% | 23.23% | 18.42% | 18.57% | 7.96% | 36.74% | 30.79% | 9.97% | 26.68% | 21.17% | 35.05% | 14.74% | 13.67% | 26.41% | 47.43% | 14.57% | 36.5% |
| Book Value per Share | 74.32 | 73.90 | 67.21 | 71.98 | 67.96 | 61.32 | 55.35 | 41.74 | 39.74 | 37.34 | 32.98 | 33.54 | 32.75 | 31.58 | 26.76 | 24.20 | 20.16 | 17.32 | 14.60 | 13.79 | 10.21 | 7.74 | 7.05 | 5.64 | 4.75 | 3.67 | 3.34 | 2.92 | 2.35 | 1.56 | 1.47 |
| Total Shareholders' Equity | 52.58B | 52.53B | 49.54B | 53.49B | 50.08B | 45.17B | 39.77B | 30.27B | 28.21B | 26.36B | 23B | 23.69B | 23.38B | 22.39B | 19.02B | 16.9B | 13.71B | 11.63B | 9.81B | 9.09B | 6.64B | 5.08B | 4.62B | 3.65B | 3.01B | 2.23B | 1.94B | 1.71B | 1.35B | 916.9M | 800.3M |
| Common Stock | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 8.4M | 8.2M | 8.1M | 8.1M | 8M | 7.9M | 7.9M | 7.7M | 7.61M | 7.29M | 3.59M | 3.54M | 3.53M | 3.41M | 3.38M | 3.37M | 1.68M | 1.67M | 1.57M | 1.56M | 1.5M | 0 | 0 | 0 |
| Retained Earnings | 48.23B | 46.89B | 44.19B | 41.07B | 39.2B | 32.83B | 27.16B | 24.17B | 25.16B | 22.81B | 20.7B | 21.01B | 20.32B | 18.01B | 15.38B | 13.06B | 10.95B | 9.21B | 8.1B | 6.82B | 5.42B | 4.32B | 3.45B | 2.72B | 2.2B | 1.92B | 1.64B | 1.32B | 978.7M | 655.7M | 506.8M |
| Treasury Stock | 0 | -11.35B | -8.16B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -795M | -207M | -3.22B | -1.75B | -2.87B | -1.03B | -368M | -3.07B | -2.79B | -1.99B | -3.02B | -2.31B | -1.43B | 214.5M | -59.2M | -36.94M | 345.39M | 346.94M | -103.1M | 542.69M | 191.99M | -109.28M | 116.04M | -74.61M | -105.97M | -69.74M | -59.13M | -34.1M | -441.6M | -263.2M | -218.8M |
| Minority Interest | 11M | 7M | 7M | 4M | 8M | 10M | 11M | 11.3M | 12.3M | 9.6M | 74M | 73.7M | 71.7M | 66.1M | 67.4M | 66.98M | 61.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill impairment risk
Total assets surged from $77.5B in 2024Q4 to $92.4B in 2026Q2, driven by a $9.8B acquisition in 2026Q2, as per recent SEC filings, while equity remained roughly flat, indicating debt-funded growth.
The $8.9B increase in total assets over six quarters was accompanied by a $11.8B rise in total liabilities, while equity only grew by $3.1B. This suggests that the balance sheet expansion is increasingly reliant on leverage, a shift from the prior period's more conservative posture. The trajectory implies that Danaher is willing to lever up for strategic acquisitions, but investors should monitor whether this leads to sustained returns above the cost of capital.
Total debt jumped from $17.1B in 2024Q4 to $26.6B in 2026Q2, lifting D/E from 0.35 to 0.50, as reported in Danaher's balance sheet, reflecting debt-funded M&A activity.
The D/E ratio of 0.50 remains moderate relative to peers like Thermo Fisher (0.74) and Bruker (0.81), but the 43% increase in debt in a single quarter warrants attention. The debt appears strategic, tied to the $9.8B acquisition outflow noted in cash flow statements, rather than operational distress. However, the increased leverage reduces financial flexibility and could pressure cash flow if integration costs or interest rates rise.
Goodwill rose to $47.4B in 2026Q2, representing 51% of total assets, up from $40.5B in 2024Q4, based on Danaher's reported figures, underscoring the company's acquisition-driven growth model.
The asset mix is increasingly intangible, with goodwill and intangibles likely dominating, while PPE remains modest at $5.8B (6.3% of assets). This suggests an asset-light operational model but carries significant impairment risk if acquired businesses underperform. The $6.9B increase in goodwill over six quarters aligns with the acquisition spree, and investors should monitor the carrying value relative to cash-generating ability.
Equity grew only 6% from $49.5B in 2024Q4 to $52.6B in 2026Q2, while assets grew 19%, as per Danaher's balance sheet, indicating that retained earnings are not keeping pace with balance sheet growth.
Retained earnings increased from $44.2B to $48.2B, reflecting cumulative net income, but the equity growth is modest relative to the debt-funded expansion. This suggests that the company is not generating enough internal capital to fund its M&A appetite, relying instead on external financing. The equity quality remains solid given consistent profitability, but the growing gap between asset and equity growth could signal a shift toward financial engineering.
Current ratio improved to 1.65 in 2026Q2 from 1.40 in 2024Q4, but cash dropped to $4.3B from $2.1B, as reported in Danaher's balance sheet, suggesting a tighter cash buffer relative to increased debt.
The current ratio remains healthy, but the absolute cash position is modest relative to the $26.6B debt load. With operating cash flow consistently strong (OCF/NI averaging 1.7), the company can service debt, but the cash buffer against shocks is thinner than it appears. The $4.3B cash covers only about 16% of total debt, and the reliance on debt markets for acquisitions could strain liquidity if credit conditions tighten.
Goodwill of $47.4B in 2026Q2, as per Danaher's balance sheet, represents over half of total assets, making the balance sheet vulnerable to impairment charges if acquired businesses underperform.
The substantial goodwill balance, accumulated through years of acquisitions, is a non-cash asset that may not be recoverable. While Danaher has a history of successful integrations, the recent $9.8B acquisition in 2026Q2 increases the risk of overpayment. If growth decelerates further or synergies fail to materialize, impairment charges could erode equity and signal a deterioration in the quality of the balance sheet. Investors should monitor segment performance and any indicators of impairment testing.
Quick answers to the most common questions about buying DHR stock.
As of 2025, Danaher Corporation (DHR) had total assets of $83.46B including $12.76B in current assets.
Danaher Corporation (DHR) carries total debt of $18.42B, offset by $4.62B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Danaher Corporation (DHR) has total shareholders' equity (book value) of $52.53B ($73.90 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Danaher Corporation (DHR) reported a current ratio of 1.87x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.